Black Rock Inc. Ocular Therapeutix, Inc Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Black Rock Inc. holds 8,063,703 shares of OCUL stock, worth $52.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,063,703

Previous 5,761,533 39.96%

Holding current value

$52.9 Million

Previous $25.7 Million 185.57%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$3.85 - $10.93 $8.86 Million - $25.2 Million	2,302,170 Added 39.96%	8,063,703 $73.4 Million
Q4 2023 Feb 13, 2024	BUY	$2.08 - $4.52 $869,398 - $1.89 Million	417,980 Added 7.82%	5,761,533 $25.7 Million
Q3 2023 Nov 13, 2023	BUY	$3.14 - $5.04 $253,187 - $406,390	80,633 Added 1.53%	5,343,553 $16.8 Million
Q2 2023 Aug 11, 2023	BUY	$4.6 - $7.64 $1.59 Million - $2.63 Million	344,611 Added 7.01%	5,262,920 $27.2 Million
Q1 2023 May 12, 2023	SELL	$2.79 - $6.27 $96,054 - $215,863	-34,428 Reduced 0.7%	4,918,309 $25.9 Million

Q4 2022 Feb 13, 2023	BUY	$2.61 - $4.41 $388,305 - $656,102	148,776 Added 3.1%	4,952,737 $13.9 Million
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $34,184 - $54,327	8,358 Added 0.17%	4,803,961 $19.9 Million
Q2 2022 Aug 12, 2022	SELL	$3.01 - $5.22 $823,891 - $1.43 Million	-273,718 Reduced 5.4%	4,795,603 $19.3 Million
Q1 2022 May 12, 2022	SELL	$4.83 - $7.35 $258,472 - $393,327	-53,514 Reduced 1.04%	5,069,321 $25.1 Million
Q4 2021 Feb 10, 2022	BUY	$6.16 - $12.07 $928,786 - $1.82 Million	150,777 Added 3.03%	5,122,835 $35.7 Million
Q3 2021 Nov 09, 2021	SELL	$9.7 - $14.34 $73,273 - $108,324	-7,554 Reduced 0.15%	4,972,058 $49.7 Million
Q2 2021 Aug 11, 2021	BUY	$13.43 - $19.16 $66.9 Million - $95.4 Million	4,979,612 New	4,979,612 $70.6 Million

Others Institutions Holding OCUL

# of Institutions

149

Shares Held

123M

Call Options Held

185K

Put Options Held

507K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $505M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account